GATTEX: payments to doctors
Payments that named GATTEX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $3M
- Providers
- 20,375
- Transactions
- 51,564
- Average per transaction
- $58
The per-transaction average — $58 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 20,375 providers the average total is $147, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $2,680,102 | 89.2% |
| Shire North American Group Inc | $318,842 | 10.6% |
| Takeda Pharmaceutical Company, Limited | $5,350 | 0.2% |